Hematology

A roundup of recent preclinical data presentations

Nanobiotix and MD Anderson Cancer Center collaborate on new product

Annual meeting and ToxExpo to unite over 300 toxicology-related companies and organizations, with more than 6,000 attendees over three da

AbbVie's partnership with TeneoBio brings it into the effort to develop BCMA-targeting immunotherapeutics against multiple myeloma

Verseon presents two precision oral anticoagulants with low bleeding at International Stroke Conference

Positive results of long-term phase of AEGIS-CKD study further demonstrate the benefits of Feraccru

Horizon to work with Rutgers University to develop and commercialize base editing platform

Company provides update on Phase 3 clinical trial of ibutinib in combo with chemo agents

Incyte announces first patient treated in Phase 3 clinical trial of itacitinib for chronic graft-versus-host disease

A new model of patient-partnered research is at the core of recently launched nonprofit organization

QIAGEN and NeoGenomics seek to explore potential of changes in FDA’s approach to advanced diagnostics and NGS tests

University of Manchester researchers able to get more data from blood of cancer patients than previously possible